How many insider declarations has Ambrose Allison filed?

Ambrose Allison has filed 3 public insider declarations with SEC (Form 4).

What is Ambrose Allison's role?

Ambrose Allison's reported role is not specified by the regulator across the filings.

Which companies does Ambrose Allison report trades for?

Ambrose Allison reports trades for Upstream Bio, Inc..

What is Ambrose Allison's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 4k€.

← Executives ★ Sign in to follow

AA

Ambrose Allison

OFFICER

·SEC (Form 4)

Upstream Bio, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€3,859

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Ambrose Allison. Director active across 1 company, notably Upstream Bio, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €4k. Activity tracked since 2 January 2026. The latest transaction was disclosed on 16 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Ambrose Allison

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Upstream Bio, Inc. (US)

申报3 总计

▼

Ambrose Allison

General Counsel高管2026年6月16日Upstream Bio, Inc.

0SEC ↗

477 股Common StockSEC:0001193125-26-274119:0

▼

Ambrose Allison

General Counsel高管2026年3月16日Upstream Bio, Inc.

US$4,41337SEC ↗

475 股@ US$9.29100.0% 占其流量Common StockSEC:0001193125-26-111121:0

◆

Ambrose Allison

General Counsel高管2026年1月2日Upstream Bio, Inc.

0SEC ↗

17,000 股0Common StockSEC:0001193125-26-004756:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AA

Ambrose Allison

OFFICER

·SEC (Form 4)

Upstream Bio, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€3,859

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Ambrose Allison. Director active across 1 company, notably Upstream Bio, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €4k. Activity tracked since 2 January 2026. The latest transaction was disclosed on 16 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.